On February 26, market debutant Aster DM Healthcare was listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE). The healthcare services provider’s issue was oversubscribed 1.3 times on February 25, as per data available on the NSE website.
Latham & Watkins acted for the underwriters in the US $153million Initial Public Offering of shares of Aster DM Healthcare Limited.
With the Initial Public Offering of Aster DM Healthcare Limited marks another outstanding year for Latham’s India Practice, following on from a successful 2017 where the team acted on transactions with an aggregate value of over US $12billion.
Latham, with a team led by Singapore Partner and India Practice Head Rajiv Gupta along with Singapore Associates Scott Calver, David Lee and Su Yuen Yang advised the Global Co-ordinators and Book Running Lead Managers Kotak Mahindra Capital Company Limited, Axis Capital Limited and Goldman Sachs (India) Securities Private Limited, and Book Running Lead Managers ICICI Securities Limited, JM Financing Limited and YES Securities (India) Limited as international legal counsel.
Advice was also provided on US tax matters by Latham’s New York Partners Jiyeon Lee-Lim and Gregory Hannibal with Associates Lauren Bewley and Amy Robertson.
Aster DM Healthcare Ltd is a private healthcare service provider, which operates in GCC (Cooperation Council for the Arab States of the Gulf) states comprising United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain, Jordan (which classifies as a GCC state as part of its GCC operations), India and the Philippines. It provides healthcare services to patients across economic segments through brands ‘Aster’, ‘Medcare’ and ‘Access’.